Rx Response, a partnership created after the 2005 Hurricane Katrina by drugmakers and health care groups to help ensure the continued flow of medicines to patients in the event of a severe public health emergency, has been put on Alert Status as concerns grow over the health threat posed by outbreaks of swine flu in the USA. Billy Tauzin, president and chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA), one of the Rx Response's founding members, said: "Americans need to know that the medicines they rely on will be available even in an emergency. Rx Response provides federal and state crisis managers with the critical information they need about the pharmaceutical supply chain to help communities affected by an emergency return to normal as quickly as possible."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze